ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,948, issued on May 12, was assigned to SUN PHARMACEUTICAL INDUSTRIES Ltd. (Mumbai, India).
"GLP-1/GIP dual agonists" was invented by Rajamannar Thennati (Vadodara, India), Vinod Sampatrao Burade (Vadodara, India), Muthukumaran Natarajan (Vadodara, India), Dhiren Rameshchandra Joshi (Vadodara, India), Manish Harendraprasad Gandhi (Vadodara, India), Chandulal Thakarshibhai Jivani (Vadodara, India), Abhishek Tiwari (Kota, India) and Krunal Harishbhai Soni (Soni, India).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to long acting glucagon-like peptide-1 and human glucose-dependent insulinotropic polypeptide (GIP) dual agonis...